Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Kisspeptin Oral vs Injectable: Comparison

The table below compares oral and injectable kisspeptin across critical research parameters. Bioavailability, mechanism integrity, reproducibility, and practical handling. Bioavailability <1%. Peptide bonds cleaved by gastric acid and proteolytic enzymes befor

This comparison does not assign a generated winner or score.

  • The table below compares oral and injectable kisspeptin across critical research parameters. Bioavailability, mechanism integrity, reproducibility, and practical handling.
  • Bioavailability
  • <1%. Peptide bonds cleaved by gastric acid and proteolytic enzymes before systemic absorption
  • 80–95%. Bypasses first-pass metabolism; intact peptide enters circulation directly
  • Injectable bioavailability is 80–950× higher; oral delivery results in functionally zero systemic exposure
  • Peptide Integrity
  • Degraded into amino acid fragments with no KISS1R binding activity
  • Intact 10-amino-acid sequence preserved from reconstitution through plasma circulation
  • Receptor activation requires intact peptide; oral degradation eliminates mechanism of action
  • Plasma Concentration
  • Undetectable. No measurable kisspeptin-10 in plasma after oral dosing in published studies
  • Dose-dependent plasma curves with Cmax at 20–30 minutes post-injection
  • Only injectable administration produces measurable, reproducible plasma levels
  • Research Reproducibility
  • High variability or null results. No consistent dose-response relationship
  • Consistent LH response curves, reproducible GnRH pulsatility modulation across studies
  • Subcutaneous injection is the validated route in peer-reviewed kisspeptin research
  • Storage Requirement
  • Often sold as capsules or tablets at room temperature. Peptide stability questionable
  • Lyophilized powder at −20°C; reconstituted solution at 2–8°C; use within 28 days
  • Proper cold-chain storage preserves peptide structure; room-temp oral products likely degraded
  • Dosing Precision
  • Difficult. Unknown effective dose due to negligible absorption; no way to titrate based on response
  • Exact. Measured volume from known concentration allows precise mcg- or nmol-level dosing
  • Injectable protocols allow dose escalation and response monitoring; oral protocols do not
More references

Related material